Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721

Watchlist Manager
Xinjiang Bai Hua Cun Pharma Tech Co Ltd Logo
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Watchlist
Price: 9.59 CNY -3.33% Market Closed
Market Cap: 3.7B CNY

Net Margin
Xinjiang Bai Hua Cun Pharma Tech Co Ltd

12.8%
Current
3%
Average
3.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.8%
=
Net Income
50.2m
/
Revenue
393.7m

Net Margin Across Competitors

No Stocks Found

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View

Market Cap
3.7B CNY
Industry
Metals & Mining

Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.

Intrinsic Value
3.17 CNY
Overvaluation 67%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.8%
=
Net Income
50.2m
/
Revenue
393.7m
What is the Net Margin of Xinjiang Bai Hua Cun Pharma Tech Co Ltd?

Based on Xinjiang Bai Hua Cun Pharma Tech Co Ltd's most recent financial statements, the company has Net Margin of 12.8%.

Back to Top